Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EXENATIDE Cause Urinary tract infection? 144 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Urinary tract infection have been filed in association with EXENATIDE (Exenatide). This represents 0.5% of all adverse event reports for EXENATIDE.

144
Reports of Urinary tract infection with EXENATIDE
0.5%
of all EXENATIDE reports
23
Deaths
68
Hospitalizations

How Dangerous Is Urinary tract infection From EXENATIDE?

Of the 144 reports, 23 (16.0%) resulted in death, 68 (47.2%) required hospitalization, and 11 (7.6%) were considered life-threatening.

Is Urinary tract infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EXENATIDE. However, 144 reports have been filed with the FAERS database.

What Other Side Effects Does EXENATIDE Cause?

Injection site haemorrhage (5,527) Device leakage (5,115) Injection site pain (4,577) Injection site mass (3,506) Blood glucose increased (3,363) Incorrect dose administered by device (3,332) Device malfunction (3,273) Wrong technique in device usage process (3,255) Device issue (2,862) Weight decreased (2,702)

What Other Drugs Cause Urinary tract infection?

ADALIMUMAB (6,375) LENALIDOMIDE (4,247) ETANERCEPT (3,915) OCRELIZUMAB (3,618) TOFACITINIB (3,179) METHOTREXATE (2,960) DALFAMPRIDINE (2,757) RITUXIMAB (2,579) CARBIDOPA\LEVODOPA (2,151) ABATACEPT (2,110)

Which EXENATIDE Alternatives Have Lower Urinary tract infection Risk?

EXENATIDE vs EXFORGE EXENATIDE vs EXJADE EXENATIDE vs EXTAVIA EXENATIDE vs EXTRANEAL EXENATIDE vs EYLEA

Related Pages

EXENATIDE Full Profile All Urinary tract infection Reports All Drugs Causing Urinary tract infection EXENATIDE Demographics